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Introduction 
Menopause  is  an  important  physiological  event,  with 
the cessation  of  menstruation  indicating the  end  of  a 
woman’s  reproductive  lifespan.
1  Menopause  is 
associated  with  a  fall  in  estrogen  levels  which 
accompanied with many health changes. Changes in the 
hormone  levels  at  menopause,  in  particular  estrogen 
deficiency are associated with an increase in body fat.
2 
Additionally,  it  sounds  an  alarm  for  women’s  health 
since  it  leads  to  elevated  blood  pressure,  insulin 
resistance  and  dyslipidemia.
3  These  changes  may 
contribute  to  increased  risks  of  metabolic  syndrome 
(MetS)  in  menopause  women.  The  features  of  the 
metabolic  syndrome  include  the  accumulation  of 
visceral  (abdominal)  adiposity,  insulin  resistance, 
hypertension,  and  dyslipidemia  (hypertriglyceridemia, 
reduced  high  density  lipoprotein  (HDL),  and  small 
dense  LDL  particles  based  on  a  set  of  diagnostic 
criteria  suggested  by  National  Cholesterol  Education 
Program Adult Treatment Panel III (NCEP-ATP III).
4 
To  date,  several  previous  studies  found  significant 
difference  in  prevalence  of  MetS  among  pre-  and 
postmenopausal women.
5-8 The prevalence of MetS in 
menopausal women was found to be 36.7% in one of 
the states, Kelantan in Malaysia.
9 
Nowadays  there  is  an  increased  demand  for  using 
plants in therapy instead of using synthetic drugs which 
may have adverse effects. Traditional medicinal plants 
are  often  cheaper,  locally  available,  and  easily 
consumable (raw or as simple medicinal preparations). 
The seeds of Nigella sativa (N. sativa) plant have been 
used to promote health and fight disease for centuries 
especially  in  the  Middle  East  and  Southeast  Asia.
10 
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Purpose: This study was conducted in menopausal women to determine the metabolic 
impact of Nigella sativa. 
Methods: Thirty subjects who were menopausal women within the age limit of 45-60 
were participated in this study and randomly allotted into two experimental groups. The 
treatment group was orally administered with N. sativa seeds powder in the form of 
capsules at a dose of 1g per day after breakfast for period of two months and compared 
to  control  group  given  placebo.  Anthropometric  and  biochemical  parameters  were 
measured at baseline, 1
st month, 2
nd month and a month after treatment completed to 
determine their body weight, serum lipid profile and fasting blood glucose (FBG). 
Results: The treatment group showed slight reduction with no significant difference in 
body weight changes of the respondents. However, significant (p<0.05) improvement 
was  observed  in  total  cholesterol  (TC),  triglycerides  (TG),  low  density  lipoprotein 
cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and blood glucose 
(p<0.05). 
Conclusion: These  results  suggested that  treatment  with  N. sativa  exert  a  protective 
effect  by  improving  lipid  profile  and  blood  glucose  which  are  in  higher  risk  to  be 
elevated during menopausal period. 
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Locally,  it  is  called  Habattus  Sauda  and  referred  as 
Black  cumin  in  English.  This  plant  has  been  a  great 
focus of research and has several traditional uses and 
consequently  has  been  extensively  studied  for  its 
chemical constituents and biological activities. A lot of 
studies  have  been  done  to  determine  the  various 
activities of N. sativa on different components of the 
metabolic  syndrome  for  example  blood  sugar,  lipid 
profile,  hypertension  and  etc.
11,12  In  spite  of  large 
number  of  pharmacological  studies  carried  out 
worldwide on N. sativa seeds, only few experimental 
studies  have  been  done  in  menopausal  women 
especially  in  Malaysia.  Moreover,  many  Malaysian 
women were consuming N. sativa in the form of coffee 
mix, oil products as a source of supplement which they 
believe can help to boost energy level. However, not 
many  aware  neither  the  actual  benefits  nor  toxicity 
effect of those N. sativa products. Previous studies on 
the various effect of N. sativa in individuals have been 
performed  on  a  heterogeneous  population  and  only 
limited data are available for the effect of N. sativa on 
metabolic syndrome in menopausal women. Thus, this 
study  was  undertaken  with  the  aim  to  know  the 
adjuvant effect of N. sativa on clinical and biochemical 
parameters of the metabolic syndrome in menopausal 
women in Klang Valley, Malaysia. 
 
Materials and Methods 
Plant materials 
N. sativa seeds samples imported from three different 
countries like Iran, India and Yemen were purchased 
through a local company named Sari Tani Desa SDN. 
BHD located in Shah Alam, Malaysia which has health 
accreditation from  Ministry  of Health,  Malaysia.  The 
seeds  were  identified  and  authenticated  by  Professor 
Dr.  Maznah  Ismail,  Head  of  the  Laboratory  of 
Molecular  Biomedicine,  Institute  of  Bioscience, 
Universiti Putra Malaysia and the voucher  specimens 
of the seeds were kept there. The identified seeds were 
analyzed  for  its  thymoquinone  (active  compound) 
content  and  among  the  seeds  that  contained  high 
thymoquinone  were  sent  back  to  the  company  for 
cleaning  and  capsulation  process  according  to  Good 
Manufacturing  Practices  (GMP).  The  N.  sativa  seeds 
were crushed into fine powder and capsulated at a dose 
of  500mg  per  capsule  and  further  bottled  with  an 
amount of 60 capsules per bottle. The bottles then were 
sealed and kept under room temperature until further use.  
 
Study Subjects  
Ethical  clearance  for  this  study  was  reviewed  and 
approved  by  the  Faculty  of  Medicine  and  Health 
Sciences  Medical  Research  Ethics  Committee, 
Universiti  Putra  Malaysia.  Respondents  for  the  study 
were  selected  based  on  the  inclusion  and  exclusion 
criteria  to  ensure  the  accurately  associated  factors  of 
metabolic  syndrome.  The  inclusion  criteria  were 
women aged 45-60, menopause for a period>12 months 
since the last regular menstruation,  presenting one or 
more features of the MetS based on the NCEP-ATP III 
definition. The exclusion criteria were women having 
endocrine or other chronic diseases, taking medication 
for chronic diseases, herbal or supplementation. 
 
Experimental design 
The  respondents  were  randomly  allotted  into  two 
experimental groups. A co-investigator was selected to 
create  subject  identification  numbers  to  assign 
respondents into the groups. A total of 18 respondents 
were assigned to N. sativa group and 17 respondents to 
placebo group. After a 2-two week’s washout period, 
the respondents received the alternative treatment for 2 
months.  Capsules  of  N.  sativa  powder  were  orally 
administered at a dose of 1g after breakfast every day 
for period of two months. A follow- up assessment a 
month later has been done after the subjects completed 
the  two  months  treatment.  The  physical  and 
pathological histories of these subjects were recorded. 
All  subjects  requested  to  maintain  their  regular 
lifestyles  including  their  dietary  intake  and  physical 
activity during the intervention period. Venous blood 
was drawn from the subjects before and after treatment 
for further analysis on the effects of N. sativa.  
 
Biochemical analysis 
Whole  blood  was  collected  in  plain  tube  and  further 
centrifuged at 2500rpm for 15min under 25 °C. Serum 
was collected in order to run the analysis of TC, TG, 
HDL-C and LDL-C levels, and FBG using commercial 
diagnostic kits (Randox Laboratories Limited, UK) on 
Selectra  XL  chemical  analyzer  (Vital  Scientific, 
Netherlands) 
 
Statistical analysis 
All  experimental  values  are  presented  as  means  ± 
standard  deviation  (SD).  Statistical  analysis  was 
performed  using  SPSS  windows  program  version  18 
(SPSS Institute, Inc., Chicago, IL, USA). The One-way 
Analysis  of  Variance  (ANOVA)  with  Bonferroni 
correction  was  used  for  analysis  of  data.  Difference 
was considered to be significant if the probability value 
was less than 0.05 (p<0.05). 
 
Results 
Body weight  
Over  the  period  of  treatment,  the  body  weight  of  N. 
sativa  group  reduced  slightly  0.32%  compare  to 
baseline (Figure 1). The body weight of placebo group 
had  no  changes.  Supplementation  with  N.  sativa  for 
eight  weeks  tended  to  reduce  the  body  weight  of  N. 
sativa groups as compared to control group, however 
no significant reduction was noticed, (p>0.05). To be 
noted, a month after treatment ends body weight of N. 
sativa group showed significant increase (p<0.05).  
 
Fasting blood glucose 
Supplementation of N. sativa for eight weeks was able 
to reduce fasting blood glucose significantly (p<0.05)  
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by 9.271% at the end of treatment. In contrast, placebo 
groups showed an elevation in blood glucose, where it 
increased  significantly  by  3.796%  (p<0.05)  over  the 
period of treatment (Figure 2). 
 
 
Figure  1.  Treatment  effect  of  N.  sativa  and  placebo  on 
body  weight  (kg).  Values  are  expressed  as  mean  +  SD. 
Same and different lower case letters indicates significant and 
no significant difference within group, respectively. A.T= one 
month after treatment ends 
 
 
 
Figure 2. Treatment effect of N. sativa and placebo on FBG 
level (mmol/L). Values are expressed as mean + SD. Same 
and  different  lower  case  letters  indicates  significant  and  no 
significant  difference  within  group,  respectively.  A.T=  one 
month after treatment ends 
 
Lipid profile  
The sequential changes in serum TC, TG, LDL-C and 
HDL-C  are  summarized  in  Table  1.  N.  sativa 
supplementations  for  eight  weeks  in  menopausal 
women  significantly  improved  TC,  TG  and  LDL-C 
which was reduced significantly by 9.52%, 35.10% and 
26.60%, respectively. HDL-C levels were increased by 
8.13% at the end of treatments; however no significant 
effect was  observed (p  > 0.05).  Whereas, in  placebo 
groups, serum TC and LDL-C were found to decreased 
significantly  (p<0.05)  by  4.36%  and  10.02%, 
respectively. HDL-C was reduced by 2.25% at the end 
of treatment with no significant difference (p<0.05). In 
contrast,  TG  was  increased  by  9.15%  at  the  end  of 
treatment without significant difference (p<0.05). 
 
Discussion  
The present study was designed to investigate the effect 
of N. sativa on some of the MetS parameters such as 
body weight, lipid profile and blood glucose level. It is 
well  documented  menopause  often  contribute  to 
increase in body weight due to hormonal changes. Fat 
substitution  in  different  tissues  (fat  accumulation  in 
visceral  tissues)  with  menopausal  transition  due  to 
decrease  in  estrogen  secretion  is  one  of  the  theories 
about  the  high  prevalence  of  MetS  in  menopause 
women.
13 In this study, body weight of the respondents 
in N. sativa group showed slight reduction compared to 
placebo group throughout the two months of treatment 
however,  not  significant  reduction  was  noticed 
(p>0.05).  In  the  same  way  from  another  study,  body 
weight was observed to reduce more in N. sativa group 
as compared to the standard group but the difference 
was  not  significant.
14  The  metabolic  pathway  of  the 
effect  of  N.  sativa  on  weight  reduction  is  yet  to  be 
explored and further studies are needed.  
 
Table 1. Treatment effect of N. sativa and placebo on lipid 
profile changes. Values are expressed as mean + SD. Same 
and different lower case letters (abcd) indicates significant and 
no significant difference within group, respectively. Same and 
different uppercase letters (AB) indicate significant difference 
between the groups by weeks, p<0.05.  
Parameters  Weeks  Nigella sativa  Placebo 
TC 
0  6.027 + 1.045aA  1.053 + 6.057aB 
4  5.613 + 0.971aA  0.796 + 5.880bA 
8  5.453 + 1.014aA  0.702 + 5.793cA 
12  5.973 + 0.830aA  0.498 + 5.873dB 
TG 
0  0.357 + 1.510aA  0.483 + 1.497aB 
4  0.320 + 1.000aA  0.369 + 1.207bB 
8  0.370 + 0.980aA  0.398 + 1.360cA 
12  0.577 + 1.187bA  0.568 + 1.393dA 
LDL-C 
0  0.925 + 4.647aA  0.597 + 4.827aB 
4  0.863 + 3.890bA  0.655 + 4.553bA 
8  0.784 + 3.413bA  0.606 + 4.343bA 
12  0.836 + 4.037bA  0.284 + 4.393cB 
HDL-C 
0  0.258 + 1.575aA  0.281 +1.357aA 
4  0.355 + 1.620bA  0.207 + 1.347bA 
8  0.330 + 1.703bA  0.255 + 1.327cA 
12  0.253 + 1.487bA  0.275 + 1.353dB 
 
The  results  showed  significant  decrease  in  the 
development  of  hyperlipidemia  among  menopausal 
women  in  N.  sativa  treatment  group  compared  to 
placebo group. This result was comparable with a study 
on oral administration of N. sativa seeds powder at a 
dose of 500 mg/ daily along with statin for 180 days 
had  improved  lipid  profile  in  patients  who’s  having 
stable coronary artery disease in Multan, Pakistan. That 
study  demonstrated  the  TC,  LDL-C  and  triglycerides 
decreased by 14.58%, 23.0% and 15.16% respectively 
whereas  HDL-C  increased  3.18%  significantly  when 
compared  with  control  group  taking  statin  only.
15 
Another study showed positive impact (p<0.05) of 2 g 
powdered N. sativa seeds intake daily for 4 weeks on 
lipid profile of hypercholesterolemic patients in Isfahan 
city, Iran. The study reported a significant decrease in 
the concentration of TC (4.78%), LDL-C (7.6%) and  
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TG  (16.65%)  compared  to  control  group  receiving 
wheat powder.
16  
The possible mechanisms of hypolipidemic action of N. 
sativa  as  suggested  from  previous  study  were  most 
probably due to an up-regulation of LDL-C molecules 
through  receptor  mediated  endocytosis.  The 
endocytosed membrane vesicles fused with lysosomes 
and  in  which  the  apoproteins  were  degraded  and  the 
cholesterol  esters  were  hydrolyzed  to  yield  free 
cholesterol. The cholesterol was then incorporated into 
plasma  as  necessary  and  excreted  from  the  body.
17 
Indeed,  lipid  lowering  activity  of  N.  sativa  through 
decreased dietary cholesterol absorption, stimulation of 
primary  bile  acid  synthesis  and  its  fecal  losses  were 
probably  contributed  from  its  dietary  soluble  fibers
18 
and  sterols.
19  Another  mechanism  involved  probably 
through  non-enzymatic  lipid  peroxidation  by 
antioxidant properties  of  N. sativa  making  liver  cells 
more  efficient  to  remove  LDL-C  from  blood  by 
increasing  LDL-C  receptor  densities  in  liver  and 
binding to apolipoprotein, apo B.
20 
The  changes  on  FBG  observed  in  the  present  study 
were  similar  with  a  number  of  clinical  studies  in 
patients with diabetes type II. Incorporation of N. sativa 
as add on therapy at a dose of 2 g/day for 12 weeks 
improves significantly (p<0.001) the blood parameters 
of glycemia and diabetes control in patients with DM 
type II.
21 Moreover, fasting blood glucose and HbA1c 
levels were found to decrease significantly (p = 0.006) 
from 102.4 + 20.8 to 91.5 + n 12.5 mg/dL in N. sativa 
treated subjects as compared to control group at the end 
of two months treatment in a randomized control trial 
conducted  in  70  healthy  subjects  attending  general 
health check up at Bagiatallah Hospital, Iran.
22  
The  hypoglycemic  effect  of  N.  sativa  was  mediated 
through multiple pharmacological actions. Study by Al-
saif,  2008  and  El-  Dakhakkhny  et  al.,  2002  reported 
that glucose lowering effects of N. sativa was due to 
improved  insulin  insensitivity  and  extra  pancreatic 
actions  of  insulin  in  diabetic  rats,  respectively.
23,24 
Fararh et al., 2005 demonstrated that hepatic glucose 
production  from  gluconeogenic  precursors  (alanine, 
glycerol  and  lactate)  was  significantly  lowered  in  N. 
sativa  treated  hamsters  indicating  the  hypoglycemic 
effect of  N.  sativa somehow  partly  mediated  through 
decreased  liver  gluconeogenesis  in  menopausal 
women.
25  Kaleem et  al.,  2006  confirmed  this  anti-
diabetic activity of N. sativa linking to its antioxidant 
effects.  Thymoquinone,  the  active  constituent  of  N. 
sativa  has  been  demonstrated  to  attenuate  oxidative 
stress  in  streptozotocin-induced  diabetic  rats  through 
preserving  pancreatic  β-  cell  integrity  leading  to 
increased insulin levels.
26 Nigella sativa was also able 
to  reduce  glucose  absorption  from  intestine  as 
evidenced by aqueous extract of N. sativa (0.1 pg/ml to 
100 ng/ ml) which exerted dose-dependent inhibition of 
sodium dependent glucose transport across isolated rat 
jejunum and controlled the activity of SGLT1, a major 
transporter of glucose in intestine.
27 
As suggested in the previous studies, the effect of N. 
sativa powder on metabolic parameters seem to be on 
multiple components and  the synergistic  action of  its 
different  constituents  including  thymoquinone  and 
nigellamine, soluble fiber, sterols, flavanoids and high 
content  of  poly-unsaturated  fatty  acids.
28,29  A  study 
evident  the  presence  of  phyto-sterols  in  amounts  of 
0.33 to 0.36% which further strengthens the protective 
effect  of  N.  sativa  interact  with  several  metabolic 
pathways of human body.
30 
 
Conclusion 
Nigella  sativa  has  beneficial  effects  on  fasting  blood 
sugar and lipid profile in menopause women suggesting 
it as one such remedy that may prove beneficial in the 
future for the prevention and treatment of Mets. Even 
though there is positive correlation with the intakes of 
N.  sativa  on  MetS  but  this  finding  is  not  enough  to 
consider N. sativa as an alternative to drugs. However, 
it  can  be  taken  as  complementary  supplement  in 
patients  having  mild  or  elevated  risk  of  MetS  which 
eventually leads to reduce dependency towards drugs.  
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